Commentary on: â€œTissue engineering: How to build a heartâ€ by Valentina Di Felice
GENERAL COMMENTARY
published: 19 March 2015
doi: 10.3389/fphys.2015.00084
Frontiers in Physiology | www.frontiersin.org 1 March 2015 | Volume 6 | Article 84
Edited by:
P. Bryant Chase,
Florida State University, USA
Reviewed by:
Christina Karatzaferi,
University of Thessaly, Greece
Teng Ma,
Florida State University, USA
Theresa Joan Grove,
Valdosta State University, USA
Dario Coletti,
Université Pierre et Marie Curie
Paris 6, France
*Correspondence:
Valentina Di Felice,
vdfelice@inwind.it;
valentina.difelice@unipa.it
Specialty section:
This article was submitted to Striated
Muscle Physiology, a section of the
journal Frontiers in Physiology
Received: 22 December 2014
Accepted: 03 March 2015
Published: 19 March 2015
Citation:
Di Felice V (2015) Commentary on:
“Tissue engineering: How to build a
heart”. Front. Physiol. 6:84.
doi: 10.3389/fphys.2015.00084
Commentary on: “Tissue
engineering: How to build a heart”
Valentina Di Felice 1, 2*
1Department of Experimental Biomedicine and Clinical Neurosciences, University of Palermo, Palermo, Italy, 2Dipartimento di
Medicina e Terapie d’Avanguardia, Strategie Biomolecolari e Neuroscienze, Istituto Euro-Mediterraneo di Scienza e
Tecnologia, Palermo, Italy
Keywords: cardiac tissue engineering, decellularization, stem cells, cardiac progenitor cells
A commentary on
Tissue engineering: how to build a heart
by Maher, B. (2013). Nature 499, 20–22. doi: 10.1038/499020a
Decellularization and recellularization of hearts from newly dead donors is the latest fashion in car-
diac tissue engineering. The first paper came out in 2008 in Nature Medicine (Ott et al., 2008), and
news has been recently published in Nature again in July 2013 (Maher, 2013).
Brendan Maher in this paper summarizes and comments on the latest important results on
decellularization of a human heart and explains the steps that are necessary to build a heart from
a decellularized organ. Two sources may be used to obtain a decellularized heart: human and pig
heart. Another issue to resolve is the time of decellularization, since the detergents used may also
destroy the architecture of the organ and adhesion molecules useful for the colonization of the
newly introduced cells. The author also highlights two main problems, which cell type to intro-
duce to the decellularized organ and how to establish and maintain the organ’s ability to beat. Many
researchers use a mixture of stem and progenitor cells from the blood vessels and from the heart;
Ott and colleagues use induced Pluripotent Stem (iPS) cells. After having chosen the best progen-
itor cell, another problem is to let the introduced cells distribute uniformly in the decellularized
scaffold, and to let them grow as they are in a natural environment. A way to improve cell growth
in these scaffolds is to use bioreactors that electrically stimulate the heart and mimic forces of a
beating heart. The most difficult step in implanting decellularized/recellularized organs is to con-
nect them to the host body. The first problem is to connect vascularization of the new organ with
the one of the host living animal. Ott’s team and others have implanted reconstructed hearts into
rats in parallel with other organs, but even if researchers have fed the organs with blood and get
them to beat for a while, none of the hearts has been able to continue for long. At the moment
researchers are able to implant recellularized hearts only in small animals.
In the last 6 years many research groups tried to remove cells from a dead organ and to repopu-
late it with stem cells or multipotent cells, immunologically matched to the patients, or decellularize
the entire organ preserving chemotactic and pro-angiogenic properties, so that they can be suc-
cessfully used for clinical tissue engineered airway clinical replacements in infants (Baiguera et al.,
2010).
It looks simple for tubular structures as the trachea, but extremely difficult for more complex
organs as the heart. This is a fine pump, working 24 h a day, with valves, tendinous chords, cham-
bers, heart walls and septa made up of different types of specialized cells, working cardiomyocytes
or cardiomyocytes of the conductive system. The cells needed to re-populate the entire heart prob-
ably derive from the same cardiac progenitor cell (Di Felice and Zummo, 2013), but until today it is
very difficult to obtain both a good number of these cells and to differentiate them into one or the
other of the four types of cells which populate the heart.
Di Felice The pros and cons of heart re-engineering
Difficulties in re-building a heart are: recreating the vascula-
ture of the heart, since the cardiac tissue is supplied by intricate
networks of capillaries difficult to reproduce; eliminating residues
of the detergents used, which may influence stem cell grow-
ing and differentiation; finding suitable donor hearts, because
available organs are often damaged by diseases or infectious
agents.
Other animal sources would be beneficial, Ott’s team is try-
ing to use decellularized porcine organs to substitute damaged
human ones. Anyway a discussion on the use of porcine substi-
tutes is still open for debate. The pig is a good candidate because
it is anatomically and physiologically similar to man, but a vio-
lent immune reaction involving the complement system occurs,
leading to hyperacute rejection (HAR). Many attempts are still
in progress to produce transgenic pigs for one of the regula-
tors of complement activation (RCA), or other molecules of the
complement system (Lavitrano and Frati, 1999).
On the other hand, one of the main issues encountered in
cardiac tissue engineering arises from the difficulty to realize
scaffolds able to match the elasto-mechanical properties of the
heart wall in which the artificial construct is thought to be inte-
grated. In this respect the “elastic” response of the scaffold should
be tailored and assessed in advance, with the aim to both meet
the physiological mechanical properties of the heart wall and the
eventual structural needs emerging after a myocardial damage.
A successful approach to cardiac tissue engineering should
aim at developing scaffolds that mimic the elasto-mechanical
properties of the heart wall, able to promptly respond to the
hemodynamic forces of the blood and resembling the dynamic
features of the heart wall. Moreover, recently it has been demon-
strated how hemodynamic forces regulate development of the
conductive system (Bressan et al., 2014), and it has been sug-
gested that the biomechanics forces present in the heart may
regulate cardiac development (Lindsey et al., 2014). With this
in mind, the elastic anisotropism, known to characterize the
mechanical properties of the heart, may be measured in an
explanted heart, and the obtained parameters may be taken into
account in order to produce a tailored biomaterial that would
exhibit a full compatibility not only at the biological level but also
for the structural and mechanical asset of the organ. A decellular-
ized heart may represent the natural scaffold whichmay resemble
the fine elasto-mechanical properties of such a complex organ.
Considering the difficulties in finding human donor hearts,
and the need to recreate the elasto-mechanical properties of the
heart wall, the best solution would be to design and print toler-
ated scaffolds on the shape of the heart of a patient. Customized
scaffolds three-dimensionally printed on the radiological images
obtained from the patient.
An alternative to decellularized organs is the use of de-novo
cellular-derived matrices (CDM) to create customized scaffolds
and organs (Fitzpatrick and Mcdevitt, 2015). Structures obtained
from the combination of natural matrices may overcome many
problems encountered in decellularized organs, such as the pres-
ence of detergents and the low availability of donor hearts. More-
over, CDMmay be used in three-dimensions printers to obtain a
personalized scaffold.
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